Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1998 Aug;74(4):258–264. doi: 10.1136/sti.74.4.258

Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS

R F Miller, M A Hall-Craggs, D C Costa, N S Brink, F Scaravilli, S B Lucas, I D Wilkinson, P J Ell, B E Kendall, M J Harrison
PMCID: PMC1758132  PMID: 9924465

Abstract

OBJECTIVES: To compare the results of magnetic resonance imaging (MRI) and thallium-201 (201Tl) SPET scanning with laboratory analyses including CSF DNA detection, brain biopsy, and necropsy in the discrimination of cerebral lymphoma and toxoplasmosis in patients with AIDS. METHODS: A retrospective study of 32 patients infected with HIV who had focal CNS lesions on MRI as a result of either lymphoma or toxoplasmosis. RESULTS: 18 patients had lymphoma, 12 had toxoplasmosis, and two had both. Toxoplasma IgG antibodies were detected in only seven patients--four with toxoplasmosis, two with lymphoma, and one with both diagnoses. Epstein-Barr virus DNA was detected in CSF of all six patients with lymphoma and none of two with toxoplasmosis. MRI showed multiple lesions in 23 patients, appearances did not discriminate between lymphoma and toxoplasmosis; nine patients had single lesions, of these eight had lymphoma (p = 0.044, two tailed Fisher's exact test) 201Tl SPET showed accumulation in 17 with lymphoma and six with toxoplasmosis (p = 0.034, two tailed Fisher's exact test). Of nine patients with single lesions on MRI and 201Tl SPET with focal accumulation eight had lymphoma. 201Tl SPET uptake ratios of > or = 2.9 were only seen with lymphoma. CONCLUSION: Knowledge of patients' toxoplasma serostatus does not aid discrimination between lymphoma and toxoplasmosis. Single lesions on MRI with focal accumulation of 201Tl strongly suggest lymphoma. Multiple lesions on MRI with 201Tl SPET uptake ratios > or = 2.9 also suggest lymphoma; uptake ratios less than 2.1 do not aid discrimination. Detection of Epstein-Barr virus DNA in CSF is highly sensitive and specific for cerebral lymphoma. 




Full Text

The Full Text of this article is available as a PDF (99.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antinori A., Ammassari A., De Luca A., Cingolani A., Murri R., Scoppettuolo G., Fortini M., Tartaglione T., Larocca L. M., Zannoni G. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology. 1997 Mar;48(3):687–694. doi: 10.1212/wnl.48.3.687. [DOI] [PubMed] [Google Scholar]
  2. Aurelius E., Johansson B., Sköldenberg B., Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol. 1993 Mar;39(3):179–186. doi: 10.1002/jmv.1890390302. [DOI] [PubMed] [Google Scholar]
  3. Bacellar H., Muñoz A., Miller E. N., Cohen B. A., Besley D., Selnes O. A., Becker J. T., McArthur J. C. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology. 1994 Oct;44(10):1892–1900. doi: 10.1212/wnl.44.10.1892. [DOI] [PubMed] [Google Scholar]
  4. Black K. L., Hawkins R. A., Kim K. T., Becker D. P., Lerner C., Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg. 1989 Sep;71(3):342–346. doi: 10.3171/jns.1989.71.3.0342. [DOI] [PubMed] [Google Scholar]
  5. Budka H., Wiley C. A., Kleihues P., Artigas J., Asbury A. K., Cho E. S., Cornblath D. R., Dal Canto M. C., DeGirolami U., Dickson D. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991 Apr;1(3):143–152. doi: 10.1111/j.1750-3639.1991.tb00653.x. [DOI] [PubMed] [Google Scholar]
  6. Chappell E. T., Guthrie B. L., Orenstein J. The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery. 1992 Jun;30(6):825–829. doi: 10.1227/00006123-199206000-00001. [DOI] [PubMed] [Google Scholar]
  7. Cingolani A., De Luca A., Ammassari A., Murri R., Linzalone A., Grillo R., Antinori A. PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol. 1996 Dec;45(6):472–476. doi: 10.1099/00222615-45-6-472. [DOI] [PubMed] [Google Scholar]
  8. Cinque P., Brytting M., Vago L., Castagna A., Parravicini C., Zanchetta N., D'Arminio Monforte A., Wahren B., Lazzarin A., Linde A. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet. 1993 Aug 14;342(8868):398–401. doi: 10.1016/0140-6736(93)92814-a. [DOI] [PubMed] [Google Scholar]
  9. D'Amico A., Messa C., Castagna A., Zito F., Galli L., Pepe G., Lazzarin A., Lucignani G., Fazio F. Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun. 1997 Aug;18(8):741–750. doi: 10.1097/00006231-199708000-00008. [DOI] [PubMed] [Google Scholar]
  10. Dina T. S. Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology. 1991 Jun;179(3):823–828. doi: 10.1148/radiology.179.3.2027999. [DOI] [PubMed] [Google Scholar]
  11. Grant A. D., Fox J. D., Brink N. S., Miller R. F. Detection of varicella-zoster virus DNA using the polymerase chain reaction in an immunocompromised patient with transverse myelitis secondary to herpes zoster. Genitourin Med. 1993 Aug;69(4):273–275. doi: 10.1136/sti.69.4.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grant I. H., Gold J. W., Rosenblum M., Niedzwiecki D., Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS. 1990 Jun;4(6):519–521. [PubMed] [Google Scholar]
  13. Hellerbrand C., Goebel F. D., Disko R. High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):869–872. doi: 10.1007/BF01691219. [DOI] [PubMed] [Google Scholar]
  14. Holland N. R., Power C., Mathews V. P., Glass J. D., Forman M., McArthur J. C. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology. 1994 Mar;44(3 Pt 1):507–514. doi: 10.1212/wnl.44.3_part_1.507. [DOI] [PubMed] [Google Scholar]
  15. Levy R. M., Bredesen D. E., Rosenblum M. L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985 Apr;62(4):475–495. doi: 10.3171/jns.1985.62.4.0475. [DOI] [PubMed] [Google Scholar]
  16. Lorberboym M., Estok L., Machac J., Germano I., Sacher M., Feldman R., Wallach F., Dorfman D. Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nucl Med. 1996 Jul;37(7):1150–1154. [PubMed] [Google Scholar]
  17. Luft B. J., Hafner R., Korzun A. H., Leport C., Antoniskis D., Bosler E. M., Bourland D. D., 3rd, Uttamchandani R., Fuhrer J., Jacobson J. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med. 1993 Sep 30;329(14):995–1000. doi: 10.1056/NEJM199309303291403. [DOI] [PubMed] [Google Scholar]
  18. Miller R. F., Lucas S. B., Hall-Craggs M. A., Brink N. S., Scaravilli F., Chinn R. J., Kendall B. E., Williams I. G., Harrison M. J. Comparison of magnetic resonance imaging with neuropathological findings in the diagnosis of HIV and CMV associated CNS disease in AIDS. J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):346–351. doi: 10.1136/jnnp.62.4.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miszkiel K. A., Hall-Craggs M. A., Miller R. F., Kendall B. E., Wilkinson I. D., Paley M. N., Harrison M. J. The spectrum of MRI findings in CNS cryptococcosis in AIDS. Clin Radiol. 1996 Dec;51(12):842–850. doi: 10.1016/s0009-9260(96)80080-8. [DOI] [PubMed] [Google Scholar]
  20. Mitchell S. M., Fox J. D., Tedder R. S., Gazzard B. G., Lightman S. Vitreous fluid sampling and viral genome detection for the diagnosis of viral retinitis in patients with AIDS. J Med Virol. 1994 Aug;43(4):336–340. doi: 10.1002/jmv.1890430404. [DOI] [PubMed] [Google Scholar]
  21. Naddaf S. Y., Akisik M. F., Aziz M., Omar W. S., Hirschfeld A., Masdeu J., Donnenfeld H., Abdel-Dayem H. M. Comparison between 201Tl-chloride and 99Tc(m)-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patients. Nucl Med Commun. 1998 Jan;19(1):47–53. doi: 10.1097/00006231-199801000-00007. [DOI] [PubMed] [Google Scholar]
  22. O'Doherty M. J., Barrington S. F., Campbell M., Lowe J., Bradbeer C. S. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 1997 Oct;38(10):1575–1583. [PubMed] [Google Scholar]
  23. O'Malley J. P., Ziessman H. A., Kumar P. N., Harkness B. A., Tall J. G., Pierce P. F. Diagnosis of intracranial lymphoma in patients with AIDS: value of 201TI single-photon emission computed tomography. AJR Am J Roentgenol. 1994 Aug;163(2):417–421. doi: 10.2214/ajr.163.2.8037042. [DOI] [PubMed] [Google Scholar]
  24. Perrons C. J., Fox J. D., Lucas S. B., Brink N. S., Tedder R. S., Miller R. F. Detection of polyomaviral DNA in clinical samples from immunocompromised patients: correlation with clinical disease. J Infect. 1996 May;32(3):205–209. doi: 10.1016/s0163-4453(96)80020-x. [DOI] [PubMed] [Google Scholar]
  25. Raffi F., Aboulker J. P., Michelet C., Reliquet V., Pelloux H., Huart A., Poizot-Martin I., Morlat P., Dupas B., Mussini J. M. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study Group. AIDS. 1997 Feb;11(2):177–184. doi: 10.1097/00002030-199702000-00007. [DOI] [PubMed] [Google Scholar]
  26. Rosenblum M. L., Levy R. M., Bredesen D. E., So Y. T., Wara W., Ziegler J. L. Primary central nervous system lymphomas in patients with AIDS. Ann Neurol. 1988;23 (Suppl):S13–S16. doi: 10.1002/ana.410230707. [DOI] [PubMed] [Google Scholar]
  27. Ruiz A., Ganz W. I., Post M. J., Camp A., Landy H., Mallin W., Sfakianakis G. N. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR Am J Neuroradiol. 1994 Nov;15(10):1885–1894. [PMC free article] [PubMed] [Google Scholar]
  28. Snider W. D., Simpson D. M., Nielsen S., Gold J. W., Metroka C. E., Posner J. B. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983 Oct;14(4):403–418. doi: 10.1002/ana.410140404. [DOI] [PubMed] [Google Scholar]
  29. Whiteman M. L., Post M. J., Berger J. R., Tate L. G., Bell M. D., Limonte L. P. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 1993 Apr;187(1):233–240. doi: 10.1148/radiology.187.1.8451420. [DOI] [PubMed] [Google Scholar]
  30. d'Arminio Monforte A., Cinque P., Vago L., Rocca A., Castagna A., Gervasoni C., Terreni M. R., Novati R., Gori A., Lazzarin A. A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol. 1997 Jan;244(1):35–39. doi: 10.1007/pl00007727. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES